SQI Diagnostics Inc (SQD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SQI Diagnostics Inc (SQD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11411
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. It provides products for immunogenicity and bioanalysis, IVD and clinical, biomarkers and assay development applications, among others. SQI Diagnostic’s technologies are used in antigens, anti-drug antibodies and dual-layer multiplexing, among others. The company provides solutions to the testing needs of three markets such as pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic testing, among others. SQI Diagnostics is headquartered in Toronto, Ontario, Canada.

SQI Diagnostics Inc (SQD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Inc, Medical Equipment, Deal Details 11
Partnerships 11
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
Equity Offering 19
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For US$3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For US$1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For US$4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional US$0.5 Million 29
Debt Offering 31
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
Asset Transactions 32
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
Acquisition 33
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc – Key Competitors 34
SQI Diagnostics Inc – Key Employees 35
SQI Diagnostics Inc – Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Financial Announcements 37
Aug 16, 2018: SQI Diagnostics announces third quarter 2018 results 37
May 10, 2018: SQI Diagnostics Reports Second Quarter 2018 Results 39
Feb 05, 2018: SQI Diagnostics Reports First Quarter 2018 Results 41
Nov 16, 2017: SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results 43
Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 45
May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results 47
Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results 49
Corporate Communications 50
Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director 50
Sep 27, 2017: SQI Diagnostics Announces Dr. Eric Brouwer Joins SQI as Chief Scientific Officer 51
Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 52
Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors 53
Other Significant Developments 54
Jul 30, 2018: SQI Diagnostics gains momentum achieving recurring revenues with major new commercial milestones 54
May 10, 2018: SQI Diagnostics and Microdrop Launch Revolutionary Disease Awareness Tests for Direct-to-Consumer Market. 56
Jan 17, 2018: SQI Signs Agreement with a Global Biotechnology Company 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
SQI Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For US$3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For US$1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For US$4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional US$0.5 Million 29
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc, Key Competitors 34
SQI Diagnostics Inc, Key Employees 35

List of Figures
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[SQI Diagnostics Inc (SQD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VSE Corporation (VSEC):企業の財務・戦略的SWOT分析
    VSE Corporation (VSEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Entercom Communications Corp (ETM):企業の財務・戦略的SWOT分析
    Summary Entercom Communications Corp (Entercom) is a provider of media and entertainment services. The company offers radio broadcasting programs. It owns and operates radio stations in various formats, including classic rocks, sports, news, talk, adult contemporary, alternative and country and othe …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Costcutter Supermarkets Group Ltd:企業の戦略・SWOT・財務分析
    Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sandoz Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products inclu …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • LGC Ltd:医療機器:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ping An Insurance (Group) Company of China, Ltd.:企業の戦略・SWOT・財務情報
    Ping An Insurance (Group) Company of China, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ping An Insurance (Group) Company of China, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • GAIL (India) Ltd (GAIL)
    GAIL (India) Ltd (GAIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Syneron Medical Ltd-医療機器分野:企業M&A・提携分析
    Summary Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Singulex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Lightstream Resources Ltd. (LTS)-石油・ガス分野:企業M&A・提携分析
    Summary Lightstream Resources Ltd. (Lightstream) is an upstream energy company that carries out the acquisition, exploration, development and production of oil and natural gas reserves with a focus on light oil. Its main operating areas include the Bakken and Mississippian formations, Cardium format …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hydra Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs to treat pain, inflammation, anxiety and other diseases. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic are …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Capricor Therapeutics Inc (CAPR):企業の財務・戦略的SWOT分析
    Summary Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced …
  • Sutures India Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Sutures India Private Limited (SIPL) is a medical device company that manufactures and markets surgical sutures. The company provides absorbable sutures, surgical tape, surgical mesh, bone wax, nonabsorbable sutures, skin stapler and surgical gloves. Its absorbable sutures include plain catg …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆